A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer - Concepedia

Concepedia

Publication | Open Access

A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer

DOI Full Paper Access

71

Citations

40

References

2020

Year

Ben Creelan, Tammie C. Yeh, Sang-We Kim, Naoyuki Nogami, Dong‐Wan Kim, Laura Q.M. Chow, Shintaro Kanda, Rosemary Taylor, Weifeng Tang, Mei Tang,

British Journal of Cancer

References

	Year	Citations

Page 1